Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.

Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, Ferlini A, Longhi S, Lorenzini M, Reggiani LB, Gagliardi C, Gallo P, Villani C, Salvi F.

JACC Cardiovasc Imaging. 2011 Jun;4(6):659-70. doi: 10.1016/j.jcmg.2011.03.016.

2.

Noninvasive risk stratification of patients with transthyretin amyloidosis.

Kristen AV, Scherer K, Buss S, aus dem Siepen F, Haufe S, Bauer R, Hinderhofer K, Giannitsis E, Hardt S, Haberkorn U, Katus HA, Steen H.

JACC Cardiovasc Imaging. 2014 May;7(5):502-10. doi: 10.1016/j.jcmg.2014.03.002. Epub 2014 Apr 9.

3.

Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.

de Haro-del Moral FJ, Sánchez-Lajusticia A, Gómez-Bueno M, García-Pavía P, Salas-Antón C, Segovia-Cubero J.

Rev Esp Cardiol (Engl Ed). 2012 May;65(5):440-6. doi: 10.1016/j.recesp.2011.12.015. Epub 2012 Mar 30. English, Spanish.

PMID:
22464102
4.

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS.

Circ Cardiovasc Imaging. 2013 Mar 1;6(2):195-201. doi: 10.1161/CIRCIMAGING.112.000132. Epub 2013 Feb 11.

5.

Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.

Glaudemans AW, van Rheenen RW, van den Berg MP, Noordzij W, Koole M, Blokzijl H, Dierckx RA, Slart RH, Hazenberg BP.

Amyloid. 2014 Mar;21(1):35-44. doi: 10.3109/13506129.2013.871250. Epub 2014 Jan 23.

PMID:
24455993
6.

Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.

Hutt DF, Quigley AM, Page J, Hall ML, Burniston M, Gopaul D, Lane T, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD.

Eur Heart J Cardiovasc Imaging. 2014 Nov;15(11):1289-98. doi: 10.1093/ehjci/jeu107. Epub 2014 Jun 16.

7.

Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.

Longhi S, Bonfiglioli R, Obici L, Gagliardi C, Milandri A, Lorenzini M, Guidalotti PL, Merlini G, Rapezzi C.

Clin Nucl Med. 2015 May;40(5):446-7. doi: 10.1097/RLU.0000000000000741.

PMID:
25742226
8.

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, Bornstein B, Salas C, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P.

Eur Heart J. 2015 Oct 7;36(38):2585-94. doi: 10.1093/eurheartj/ehv338. Epub 2015 Jul 28.

PMID:
26224076
9.

Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).

Bhuiyan T, Helmke S, Patel AR, Ruberg FL, Packman J, Cheung K, Grogan D, Maurer MS.

Circ Heart Fail. 2011 Mar;4(2):121-8. doi: 10.1161/CIRCHEARTFAILURE.109.910455. Epub 2010 Dec 29.

10.

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, Leone O, Farsad M, Ciliberti P, Bacchi-Reggiani L, Fallani F, Branzi A, Rapezzi C.

J Am Coll Cardiol. 2005 Sep 20;46(6):1076-84.

11.

Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.

Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, Ferlini A, Salvi F, Gallo P, Gagliardi C, Branzi A.

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):470-8. doi: 10.1007/s00259-010-1642-7. Epub 2010 Nov 11.

PMID:
21069320
12.

Cardiac amyloidosis: updates in diagnosis and management.

Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A.

Arch Cardiovasc Dis. 2013 Oct;106(10):528-40. doi: 10.1016/j.acvd.2013.06.051. Epub 2013 Sep 23. Review.

13.

Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.

Coutinho MC, Cortez-Dias N, Cantinho G, Conceição I, Oliveira A, Bordalo e Sá A, Gonçalves S, Almeida AG, de Carvalho M, Diogo AN.

Circ Cardiovasc Imaging. 2013 Sep;6(5):627-36. doi: 10.1161/CIRCIMAGING.112.000367. Epub 2013 Jul 5.

14.

(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.

Pilebro B, Suhr OB, Näslund U, Westermark P, Lindqvist P, Sundström T.

Ups J Med Sci. 2016;121(1):17-24. doi: 10.3109/03009734.2015.1122687. Epub 2016 Feb 5.

15.

High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathy.

Quarta CC, Obici L, Guidalotti PL, Pieroni M, Longhi S, Perlini S, Verga L, Merlini G, Rapezzi C.

Amyloid. 2013 Mar;20(1):48-51. doi: 10.3109/13506129.2012.746938. Epub 2012 Dec 12.

PMID:
23231421
16.

99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.

Puille M, Altland K, Linke RP, Steen-Müller MK, Kiett R, Steiner D, Bauer R.

Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):376-9.

PMID:
12002714
17.

Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.

Longhi S, Quarta CC, Milandri A, Lorenzini M, Gagliardi C, Manuzzi L, Bacchi-Reggiani ML, Leone O, Ferlini A, Russo A, Gallelli I, Rapezzi C.

Amyloid. 2015;22(3):147-55. doi: 10.3109/13506129.2015.1028616. Epub 2015 Jun 5.

PMID:
25997105
18.
19.

The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy.

Bauer R, Dikow N, Brauer A, Kreuter M, Buss S, Evers C, Röcken C, Schnabel PA, Hinderhofer K, Ehlermann P, Katus HA, Kristen AV.

Amyloid. 2014 Dec;21(4):267-75. doi: 10.3109/13506129.2014.967846. Epub 2014 Oct 7.

PMID:
25291558
20.

Prognostic significance of strain Doppler imaging in light-chain amyloidosis.

Koyama J, Falk RH.

JACC Cardiovasc Imaging. 2010 Apr;3(4):333-42. doi: 10.1016/j.jcmg.2009.11.013.

Items per page

Supplemental Content

Write to the Help Desk